Logo-ipp

Original

1. Effect of high dose versus low dose of atorvastatin therapy on inflammation and coagulation factors in type 2 diabetic patients; a randomized clinical trial study
Mitra Niafar ORCID, Amir Bahrami, Neda Lotfi Yagin, Farzad Najafipour, Naser Aghamohammadzadeh, Vahideh Sadra* ORCID
Immunopathol Persa. 2019;5(1): e01. doi: 10.15171/ipp.2019.01
Scopus ID: 85077302600    
Article
PDF
XML
Cited By:
4
3
Original

2. Anti-inflammatory effects of different statins in rheumatoid arthritis; a randomized double-blind controlled clinical trial
Mansoor Karimifar ORCID, Mansour Salesi, Rasoul Ghasemian*, Mozhgan Karimifar, Ziba Farajzadegan, Mohammad Gholamnezhad
Immunopathol Persa. 2019;5(1): e09. doi: 10.15171/ipp.2019.09
Scopus ID: 85087111992    
Article
PDF
XML
Cited By:
4
3
Original

3. High versus low doses of rosuvastatin on postoperative outcomes of coronary artery bypass grafting; a double-blind clinical trial
Fardin Mirbolouk ORCID, Arsalan Salari ORCID, Heidar Dadkhah Tirani ORCID, Mani Moayerifar ORCID, Mahboobe Gholipour* ORCID, Mahdieh Sheikhi* ORCID
Immunopathol Persa. 2021;7(2): e15. doi: 10.34172/ipp.2021.15
Scopus ID: 85112514636    
Article
PDF
XML
Cited By:
1
1

Meta-analysis

4. Statins and the risk of colorectal cancer; a systematic review and meta-analysis of cohort and case-control studies
Mehrdad Abbaszadeh ORCID, Fahimeh Bayrami ORCID, Samaneh Zandifar ORCID, Hamid Reza Hemmati ORCID, Ali Valadkhani* ORCID, Alireza Peimanfar* ORCID
Immunopathol Persa. 2025;. doi: 10.34172/ipp.2024.40597
Article
PDF
XML
Cited By: